Morning Headlines 6/2/23
FDA-approved Alzheimer’s drugs will be covered by Medicare, with some limitations, CMS says
CMS announces that Medicare Part B will cover the use of FDA-approved monoclonal antibodies to slow the progression of Alzheimer’s disease, but will require doctors to populate patient registries for real-world tracking of the performance of those treatments.
Biden plans to pick physician Mandy Cohen to lead CDC
President Biden will reportedly choose Aledade executive and former North Carolina health secretary Mandy Cohen, MD, MPH as director of the CDC.
Behavioral healthcare software vendor Lightning Step sells its Ava Billing & Consulting subsidiary to RCM company Medusind.
Fun framing using Seinfeld. Though in a piece about disrupting healthcare, it’s a little striking that patients, clinicians, and measurable…